Gratus Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $20.1M | Buy |
162,476
+11,373
| +8% | +$1.46M | 0.81% | 30 |
|
|
2024
Q1 | $19.9M | Buy |
151,103
+10,148
| +7% | +$1.25M | 0.92% | 28 |
|
|
2023
Q4 | $15.4M | Buy |
140,955
+40,073
| +40% | +$4.16M | 0.87% | 34 |
|
|
2023
Q3 | $10.4M | Buy |
100,882
+91,863
| +1,019% | +$9.9M | 0.7% | 47 |
|
|
2023
Q2 | $1.04M | Sell |
9,019
-521
| -5% | -$59.2K | 0.07% | 135 |
|
|
2023
Q1 | $1.01M | Sell |
9,540
-1,452
| -13% | -$157K | 0.08% | 125 |
|
|
2022
Q4 | $1.22M | Sell |
10,992
-436
| -4% | -$44.6K | 0.1% | 120 |
|
|
2022
Q3 | $984K | Buy |
11,428
+3,492
| +44% | +$312K | 0.1% | 116 |
|
|
2022
Q2 | $724K | Buy |
7,936
+1,959
| +33% | +$174K | 0.08% | 118 |
|
|
2022
Q1 | $490K | Sell |
5,977
-121
| -2% | -$9.54K | 0.05% | 142 |
|
|
2021
Q4 | $467K | Buy |
6,098
+213
| +4% | +$17K | 0.04% | 149 |
|
|
2021
Q3 | $442K | Buy |
5,885
+37
| +0.6% | +$2.81K | 0.05% | 140 |
|
|
2021
Q2 | $455K | Sell |
5,848
-814
| -12% | -$60.5K | 0.05% | 138 |
|
|
2021
Q1 | $490K | Sell |
6,662
-342
| -5% | -$25.2K | 0.06% | 138 |
|
|
2020
Q4 | $547K | Buy |
7,004
+374
| +6% | +$28.6K | 0.07% | 125 |
|
|
2020
Q3 | $525K | Sell |
6,630
-1,228
| -16% | -$96.2K | 0.08% | 119 |
|
|
2020
Q2 | $580K | Sell |
7,858
-70
| -0.9% | -$5.27K | 0.1% | 115 |
|
|
2020
Q1 | $582K | Sell |
7,928
-193
| -2% | -$15.2K | 0.11% | 118 |
|
|
2019
Q4 | $705K | Sell |
8,121
-35
| -0.4% | -$2.88K | 0.11% | 116 |
|
|
2019
Q3 | $655K | Buy |
8,156
+405
| +5% | +$32.5K | 0.11% | 118 |
|
|
2019
Q2 | $620K | Buy |
7,751
+30
| +0.4% | +$2.3K | 0.1% | 118 |
|
|
2019
Q1 | $613K | Sell |
7,721
-167
| -2% | -$12.5K | 0.1% | 123 |
|
|
2018
Q4 | $575K | Buy |
7,888
+720
| +10% | +$50.8K | 0.12% | 120 |
|
|
2018
Q3 | $485K | Buy |
7,168
+463
| +7% | +$29.5K | 0.07% | 133 |
|
|
2018
Q2 | $388K | Sell |
6,705
-1,342
| -17% | -$75.7K | 0.06% | 134 |
|
|
2018
Q1 | $418K | Buy |
8,047
+4,191
| +109% | +$226K | 0.06% | 141 |
|
|
2017
Q4 | $207K | Sell |
3,856
-578
| -13% | -$32K | 0.03% | 169 |
|
|
2017
Q3 | $271K | Sell |
4,434
-567
| -11% | -$34.4K | 0.04% | 157 |
|
|
2017
Q2 | $306K | Sell |
5,001
-235
| -4% | -$14.3K | 0.04% | 152 |
|
|
2017
Q1 | $317K | Buy |
5,236
+242
| +5% | +$14.7K | 0.05% | 146 |
|
|
2016
Q4 | $281K | Sell |
4,994
-134
| -3% | -$7.84K | 0.04% | 152 |
|
|
2016
Q3 | $305K | Buy |
5,128
+298
| +6% | +$17.4K | 0.04% | 151 |
|
|
2016
Q2 | $265K | Sell |
4,830
-2,572
| -35% | -$137K | 0.04% | 156 |
|
|
2016
Q1 | $374K | Buy |
7,402
+1,157
| +19% | +$56.7K | 0.08% | 49 |
|
|
2015
Q4 | $315K | Buy |
6,245
+633
| +11% | +$31.9K | 0.07% | 75 |
|
|
2015
Q3 | $264K | Buy |
5,612
+986
| +21% | +$52.4K | 0.06% | 84 |
|
|
2015
Q2 | $251K | Buy |
4,626
+62
| +1% | +$3.48K | 0.06% | 83 |
|
|
2015
Q1 | $250K | Buy |
+4,564
| New | +$258K | 0.06% | 82 |
|
Other funds holding MRK
Gratus Capital's MRK Position: Q2 2024 in Review
Gratus Capital increased its Merck (MRK) stake by 7.5% in Q2 2024, buying an estimated $1.46M and bringing the position to 162,476 shares worth $20.1M. The position accounts for 0.81% of the portfolio, ranked #30.
Gratus Capital first reported a position in MRK in Q1 2015 and has held it in 38 quarters since. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.
- Gratus Capital held 162,476 shares of Merck worth $20.1M as of Q2 2024.
- Gratus Capital bought 11,373 Merck shares in Q2 2024, an estimated $1.46M.
- Merck made up 0.81% of Gratus Capital's portfolio in Q2 2024, its #30 holding.
- Gratus Capital first reported a position in Merck in Q1 2015 and has held it in 38 quarters since.
- 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.
Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.